| Literature DB >> 33184320 |
Alper Akın1, Edip Unal2, Ruken Yildirim2, Mehmet Ture3, Hasan Balik3, Yusuf Kenan Haspolat2.
Abstract
Subclinical hypothyroidism (SH) may influence both ventricular functions. The aim of this study was to evaluation the findings of Tissue Doppler Imaging (TDI) and other echocardiography modalities in children with SH. We compared left ventricular mass index (LVMI) and TDI parameters of patients with SH and children with euthyroidism. Subclinical hypothyroidism was diagnosed when thyroid stimulating hormone level was higher than the reference value of the laboratory (> 4.2 mIU/L) and free thyroxine level was in normal range. The study included a group of 35 patients with SH and a control group of 38 children with euthyroidism (mean age was 7.6 ± 3.5 years and 9.0 ± 2.4 years, respectively). LVMI was significantly higher in the patient group (p = 0.005). TDI parameters including mitral septal ejection time was lower (p = 0.003) and mitral septal myocardial performance index was higher (p = 0.009) in the patient group. Right ventricular TDI revealed that tricuspid lateral E/Ea and tricuspid septal E/Ea were higher (p = 0.015 and p = 0.024, respectively) and tricuspid septal Ea/Aa and ejection time were lower (p = 0.018 and p = 0.017, respectively) in the patient group. SH may lead to increase LVMI. Left ventricular systolic and diastolic TDI parameters (lower mitral septal ejection time, higher mitral septal myocardial performance index) as well as right ventricular systolic (lower tricuspid septal ejection time) and diastolic (higher tricuspid septal and lateral E/Ea, lower tricuspid septal Ea/Ea) functions may be also impaired in children with subclinical hypothyroidism. TDI is a useful method used for the assessment of the effect of SH on cardiac functions.Entities:
Year: 2020 PMID: 33184320 PMCID: PMC7661521 DOI: 10.1038/s41598-020-76327-4
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Demographic and laboratory characteristic of the study groups.
| SH group (n = 35) | Control group (n = 38) | ||
|---|---|---|---|
| Gender (female/male) | 19/16 | 20/18 | 0.887 |
| Age (year) | 7.6 ± 3.5 6.5 (3.5–15.0) | 9.0 ± 2.4 8.7 (4.5–15.0) | 0.232 |
| Weight (kg) | 25.4 ± 11.8 21.0 (12.8–63.0) | 29.3 ± 10.3 27.7 (16.0–57.0) | 0.141 |
| Height (cm) | 121.2 ± 19.44 | 128.0 ± 13.33 | 0.076 |
| BMI (kg/m2) | 16.4 ± 2.4 15.7 (13.7–25.0) | 16.6 ± 2.8 15.6 (12.2–23.5) | 0.899 |
| Systolic blood pressure (mmHg) | 104.5 ± 5.5 | 106.3 ± 6.7 | 0.241 |
| Diastolic blood pressure (mmHg) | 63.3 ± 5.6 | 65.8 ± 7.6 | 0.150 |
| Heart rate (beats a minute) | 92.0 ± 16.4 | 87.0 ± 15.1 | 0.182 |
| TSH (mIU/L) | 7.5 ± 2.3 6.7 (5.0–14.5) | 2.4 ± 0.7 2.3 (1.1–3.9) | < 0.001 |
| fT4 (pmol/L) | 16.2 ± 1.8 16.6 (12.6–19.0) | 16.9 ± 1.9 16.4 (13.2–21.4) | 0.164 |
| fT3 (pmol/L) | 6.6 ± 0.6 6.7 (5.6–7.2) | 6.7 ± 0.7 6.6 (4.6–8.7) | 0.655 |
Data are given as mean ± SD, and median (range).
BMI body mass index, free triiodothyronine, fT4 free thyroxine, SH subclinical hypothyroidism, TSH thyroid-stimulating hormone.
M-Mode echocardiographic measurements of the study groups.
| SH group (n = 35) | Control group (n = 38) | ||
|---|---|---|---|
| LVEDd (cm) | 3.4 ± 0.5 | 3.6 ± 0.3 | 0.139 |
| LVESd (cm) | 2.0 ± 0.3 | 2.2 ± 0.2 | 0.023 |
| FS (%) | 39.8 ± 4.2 | 38.2 ± 3.1 | 0.088 |
| EF (%) | 71.2 ± 4.9 | 69.5 ± 3.7 | 0.094 |
| IVSd (cm) | 0.6 ± 0.1 | 0.6 ± 0.1 | 0.160 |
| PWd (cm) | 0.6 ± 0.11 | 0.5 ± 0.1 | 0.105 |
| LVMI (g/m2) | 68.1 ± 19.8 | 56.0 ± 15.1 | 0.005 |
Data are given as mean ± SD.
EF ejection fraction, FS fractional shortening, IVSd thickness of the interventricular septum, LVMI left ventricle mass index, LVEDd left ventricle end-diastolic diameter, LVESd left ventricle end-systolic diameter, PWd thickness of the left ventricle posterior wall, SH subclinical hypothyroidism.
Pulse-wave Doppler measurements of the study groups.
| SH group (n = 35) | Control group (n = 38) | p value | |
|---|---|---|---|
| Mitral E velocity (m/s) | 0.88 ± 0.14 | 0.81 ± 0.11 | 0.020 |
| Mitral A velocity (m/s) | 0.54 ± 0.11 | 0.52 ± 0.10 | 0.405 |
| Mitral E/A | 1.63 ± 0.25 | 1.55 ± 0.25 | 0.171 |
| AT (ms) | 77.83 ± 14.95 | 84.58 ± 13.21 | 0.044 |
| DT (ms) | 94.29 ± 25.17 | 103.24 ± 16.64 | 0.075 |
| ET (ms) | 285.14 ± 46.26 | 286.89 ± 41.13 | 0.865 |
| Tricuspid E velocity (m/s) | 0.72 ± 0.11 | 0.69 ± 0.12 | 0.312 |
| Tricuspid A velocity (m/s) | 0.52 ± 0.11 | 0.49 ± 0.11 | 0.360 |
| Tricuspid E/A | 1.42 ± 0.23 | 1.39 ± 0.19 | 0.579 |
| AT (ms) | 92.83 ± 23.24 | 91.79 ± 19.46 | 0.836 |
| DT (ms) | 108.43 ± 26.85 | 119.76 ± 28.76 | 0.087 |
| ET (ms) | 278.00 ± 53.52 | 278.24 ± 45.54 | 0.984 |
Data are given as mean ± SD.
AT acceleration time, DT deceleration time, ET ejection time, mitral A late transmitral flow velocity, mitral E early transmitral flow velocity, tricuspid A late transtricuspid flow velocity, tricuspid E early transtricuspid flow velocity, SH subclinical hypothyroidism.
TDI parameters of the study groups.
| SH group (n 35) | Control group (n 38) | p value | |
|---|---|---|---|
| Sa (m/s) | 0.05 ± 0.01 | 0.05 ± 0.01 | 0.835 |
| Ea (m/s) | 0.11 ± 0.02 | 0.10 ± 0.01 | 0.280 |
| Aa (m/s) | 0.07 ± 0.02 | 0.06 ± 0.01 | 0.252 |
| Ea/Aa | 1.68 ± 0.28 | 1.68 ± 0.23 | 0.915 |
| IVRT (ms) | 65.11 ± 17.53 | 64.53 ± 12.18 | 0.867 |
| IVCT (ms) | 58.26 ± 13.71 | 60.63 ± 12.43 | 0.440 |
| ET (ms) | 234.06 ± 25.42 | 244.95 ± 30.63 | 0.104 |
| AT (ms) | 50.77 ± 11.71 | 51.50 ± 11.47 | 0.789 |
| DT (ms) | 67.09 ± 10.73 | 71.00 ± 13.37 | 0.175 |
| E/Ea | 8.01 ± 2.16 | 7.57 ± 1.65 | 0.331 |
| MPI | 0.53 ± 0.12 | 0.52 ± 0.10 | 0.585 |
| Sa (m/s) | 0.07 ± 0.01 | 0.06 ± 0.01 | 0.349 |
| Ea (m/s) | 0.11 ± 0.01 | 0.11 ± 0.01 | 0.430 |
| Aa (m/s) | 0.07 ± 0.02 | 0.06 ± 0.08 | 0.071 |
| Ea/Aa | 1.59 ± 0.30 | 1.67 ± 0.21 | 0.210 |
| IVRT (ms) | 62.51 ± 17.45 | 57.84 ± 10.42 | 0.175 |
| IVCT (ms) | 53.86 ± 11.40 | 52.63 ± 10.26 | 0.632 |
| ET (ms) | 239.26 ± 24.89 | 255.50 ± 19.31 | 0.003 |
| AT (ms) | 47.97 ± 8.83 | 50.89 ± 10.12 | 0.195 |
| DT (ms) | 69.94 ± 16.30 | 78.39 ± 18.10 | 0.040 |
| E/Aa | 7.57 ± 1.57 | 7.10 ± 1.06 | 0.147 |
| MPI | 0.49 ± 0.11 | 0.43 ± 0.06 | 0.009 |
| Sa (m/s) | 0.11 ± 0.02 | 0.11 ± 0.01 | 0.582 |
| Ea (m/s) | 0.15 ± 0.02 | 0.15 ± 0.02 | 0.242 |
| Aa (m/s) | 0.11 ± 0.03 | 0.11 ± 0.02 | 0.574 |
| Ea/Aa | 1.40 ± 0.30 | 1.49 ± 0.26 | 0.202 |
| IVRT (ms) | 60.43 ± 10.02 | 57.32 ± 11.41 | 0.339 |
| IVCT (ms) | 60.77 ± 14.60 | 59.11 ± 11.25 | 0.585 |
| ET (ms) | 246.43 ± 35.33 | 249.71 ± 23.12 | 0.643 |
| AT (ms) | 65.69 ± 15.86 | 70.87 ± 16.41 | 0.135 |
| DT (ms) | 82.74 ± 22.45 | 91.71 ± 21.09 | 0.083 |
| E/Ea | 4.92 ± 0.97 | 4.40 ± 0.80 | 0.015 |
| MPI | 0.50 ± 0.13 | 0.46 ± 0.08 | 0.154 |
| Sa (m/s) | 0.08 ± 0.01 | 0.07 ± 0.01 | 0.262 |
| Ea (m/s) | 0.11 ± 0.02 | 0.12 ± 0.01 | 0.245 |
| Aa (m/s) | 0.08 ± 0.02 | 0.07 ± 0.02 | 0.520 |
| Ea/Aa | 1.54 ± 0.30 | 1.69 ± 0.24 | 0.018 |
| IVRT (ms) | 57.94 ± 16.13 | 55.55 ± 8.97 | 0.443 |
| IVCT (ms) | 52.26 ± 10.03 | 53.68 ± 10.01 | 0.545 |
| ET (ms) | 242.17 ± 26.80 | 255.42 ± 19.37 | 0.017 |
| AT (ms) | 51.97 ± 13.19 | 54.50 ± 6.96 | 0.304 |
| DT (ms) | 70.63 ± 17.43 | 75.53 ± 12.36 | 0.174 |
| E/Ea | 6.30 ± 1.18 | 5.67 ± 1.14 | 0.024 |
| MPI | 0.46 ± 0.10 | 0.43 ± 0.05 | 0.156 |
| Sa (m/s) | 0.05 ± 0.00 | 0.05 ± 0.01 | 0.070 |
| Ea (m/s) | 0.10 ± 0.02 | 0.10 ± 0.01 | 0.722 |
| Aa (m/s) | 0.06 ± 0.01 | 0.05 ± 0.00 | 0.022 |
| Ea/Aa | 1.76 ± 0.31 | 1.90 ± 0.23 | 0.032 |
| IVRT (ms) | 57.80 ± 14.53 | 57.68 ± 13.32 | 0.972 |
| IVCT (ms) | 53.06 ± 11.36 | 55.13 ± 9.58 | 0.401 |
| ET (ms) | 244.63 ± 23.39 | 251.26 ± 18.88 | 0.185 |
| AT (ms) | 52.97 ± 9.38 | 56.00 ± 9.13 | 0.167 |
| DT (ms) | 55.54 ± 8.46 | 60.97 ± 11.23 | 0.023 |
| MPI | 0.46 ± 0.08 | 0.44 ± 0.07 | 0.379 |
Data are given as mean ± SD.
A atrial diastolic wave, AT acceleration time, DT deceleration time, E early transvalvular flow velocity, E early diastolic wave, ET ejection time, IVCT isovolumic contraction time, IVRT isovolumic relaxation time, MPI myocardial performance index, S myocardial systolic wave, SH subclinical hypothyroidism, TDI tissue Doppler imaging.